Medical Robotics News

RSS

Lawnwood Regional Medical Center & Heart Institute Procures Mazor Robotics’ Renaissance System

Mazor Robotics Ltd., the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that Lawnwood Regional Medical Center & Heart Institute, located in Ft. Pierce, FL, has purchased its first Renaissance system.

From MAZOR Robotics Inc. 12 Nov 2013

CWRU Team Receives NIH Grant to Develop MRI-Guided Robotic Heart Catheter

In a matter of years, a doctor may see real-time images of a patient’s beating heart and steer a robotic catheter through its chambers using the push and pull of magnetic fields while the patient lies inside a magnetic resonance imager.

12 Nov 2013

Technological Advances Dramatically Improve Viability of Robotic Prostheses

Recent advances in robotics technology make it possible to create prosthetics that can duplicate the natural movement of human legs. This capability promises to dramatically improve the mobility of lower-limb amputees, allowing them to negotiate stairs and slopes and uneven ground, significantly reducing their risk of falling as well as reducing stress on the rest of their bodies.

8 Nov 2013

Rethink Robotics Partners with Nihon Binary to Distribute Baxter Research Robot in Japan

Rethink Robotics today announced it has expanded the distribution of its Baxter Research Robot into the Asian market by signing an exclusive partnership with Nihon Binary, a leading robotics and technology supplier, to distribute the revolutionary humanoid research robot in Japan.

8 Nov 2013

Endomicroscopy with Cellvizio Successfully Used in Patients Treated With Robotic Assisted Radical Prostatectomy

Mauna Kea Technologies announced today that Joseph C. Liao MD, associate professor of urology, Stanford University, has successfully used endomicroscopy with Cellvizio for the first time in eight patients treated with robotic assisted radical prostatectomy (RARP) procedures. Results were presented in a poster presentation at the 2013 World Congress of Endourology Meeting in New Orleans in October where the procedure was also named “Best New Innovation.”

7 Nov 2013

Mazor Robotics Closes Public Offering of American Depositary Shares

Mazor Robotics Ltd., (the “Company”) the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today the closing of its previously announced public offering of 2,760,000 American Depositary Shares (“ADSs”), including ADSs issued pursuant to the underwriters option to purchase additional shares, at a price of $17.00 per ADS, bringing total gross proceeds from the offering to $46,920,000, before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

From MAZOR Robotics Inc. 7 Nov 2013

Robotic-Assisted Lung Surgery Associated With Significantly Lower Death Rates

A new study comparing open surgery, video-assisted thoracic surgery (VATS), and robotic-assisted surgery to remove diseased lung tissue found that robotic-assisted surgery is associated with significantly lower death rates, lower overall complication rates, and shorter hospital stays compared with open surgery. Researchers also concluded that robotic-assisted surgery is an appropriate alternative to VATS.

From Intuitive Surgical, Inc. 6 Nov 2013

Corindus Vascular Robotics Presents Live Robotic-Assisted Coronary Angioplasty During TCT Conference

Corindus Vascular Robotics the leader in precision vascular robotics, presented a live percutaneous coronary intervention (PCI), or coronary angioplasty, during the Transcatheter Cardiovascular Therapeutics (TCT) conference on Oct. 29.

4 Nov 2013

Ground-breaking Project to Create New Generation of Cardiac Surgery Robots

A ground breaking project in Poland to create a new generation of advanced cardiac surgery robots is utilising the latest in portable analysers to improve electrical safety testing during product development.

From Rigel Medical 1 Nov 2013

New CorPath One Stent Program Launched by Corindus Vascular Robotics

Corindus Vascular Robotics, a leading provider of precision medical robotics, today announced the launch of its CorPath One Stent Program. The goal of the program is to raise awareness of the potential to decrease longitudinal geographic miss (LGM) caused by sub-optimal stent placement, as well as the patient safety and financial benefits that can result from using the CorPath Vascular Robotic System to place just one stent per lesion in coronary angioplasty procedures.

31 Oct 2013